Orrick Herrington & Sutcliffe LLP represented Kineta on the matter. Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology…
Kineta’s $3 Million Registered Direct Offering


Orrick Herrington & Sutcliffe LLP represented Kineta on the matter. Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology…
…